ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0847

Cnm-Positive Streptococcus mutans Is Specifically Associated with IgAN in Various Kidney Diseases

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Misaki, Taro, Seirei Hamamatsu Byoin, Hamamatsu, Shizuoka Prefecture, Japan
  • Suehiro, Yuto, Osaka Daigaku, Suita, Osaka Prefecture, Japan
  • Naka, Shuhei, Okayama Daigaku, Okayama, Okayama Prefecture, Japan
  • Matsuoka, Daiki, Okayama Daigaku, Okayama, Okayama Prefecture, Japan
  • Kana, Suehara, Okayama Daigaku, Okayama, Okayama Prefecture, Japan
  • Ito, Seigo, Jieitai Iruma Byoin, Iruma, Saitama Prefecture, Japan
  • Nomura, Ryota, Hiroshima Daigaku, Higashihiroshima, Hiroshima Prefecture, Japan
  • Nagasawa, Yasuyuki, Hyogo Ika Daigaku, Nishinomiya, Hyogo Prefecture, Japan
  • Matsumoto-Nakano, Michiyo, Okayama Daigaku, Okayama, Okayama Prefecture, Japan
  • Nakano, Kazuhiko, Osaka Daigaku, Suita, Osaka Prefecture, Japan
Background

We previously reported an association between the presence of cnm-positive Streptococcus mutans in the oral cavity and IgA nephropathy (IgAN). However, it remains unclear whether this association is specific to IgAN among various kidney diseases. This study aimed to evaluate the association between cnm-positive Streptococcus mutans and various kidney diseases in patients who underwent renal biopsy.

Methods

A total of 294 patients who underwent renal biopsy and provided informed consent between May 2017 and March 2024 were enrolled in the chronic kidney disease (CKD) group. The control group comprised 81 individuals with an estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m2 and no proteinuria. Saliva samples were collected from all participants, stored at −20°C, and analyzed using polymerase chain reaction (PCR) to detect S. mutans and cnm-positive S. mutans. Associations between cnm-positive S. mutans and clinical parameters were subsequently assessed.

Results

The prevalence of cnm-positive S. mutans was significantly higher in the CKD group compared to the control group (21.8% vs. 11.1%, p < 0.05). Logistic regression analysis adjusted for age and sex confirmed a significant association between cnm-positive S. mutans and CKD (p < 0.05).
Among various kidney diseases, higher prevalences of cnm-positive S. mutans were observed in patients with lupus nephritis (31.6%), membranous nephropathy (29.2%), and IgAN (23.6%), suggesting a potential association with immune complex–mediated diseases. However, logistic regression analysis identified a statistically significant association only between cnm-positive S. mutans and IgAN (p < 0.05).

Conclusion

cnm-positive S. mutans may be associated with immune complex–mediated kidney diseases, with a specific and significant association observed in patients with IgA nephropathy.

Digital Object Identifier (DOI)